Single Dose Study Of PF-04171327 And Prednisone On Carbohydrate Metabolism

Completed · Phase 1

Conditions studied: Healthy

In brief

This study will investigate the effect of a single dose of PF-04171327 or prednisone on calculated measures of glucose tolerance and insulin resistance by using a modified oral glucose tolerance test

Key facts

Study ID

NCT01199900

Run by

Pfizer

People needed

18

Starts

2010-08-01

Expected to finish

2010-09-01

Last updated by the study team

2010-12-17

Who can join

Age: 18 and older, up to 55. Sex: male. Healthy volunteers: accepted.

You may qualify if…

• BMI 17.5 to 30.5 kg/m2 and total body weight >50 kg

You may not qualify if…

• Fasting glucose above the limits of the reference range for healthy individuals
• "No treatment" Oral Glucose Tolerance Test (OGTT) indicative of impaired fasting glucose or impaired glucose tolerance
• Severe acute or chronic medical or psychiatric condition or laboratory abnormality that may increase the risk associated with study participation

Where it is running

• Pfizer Investigational Site — Kalamazoo, Michigan, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.